Iron Triangle Partners LP
- SEC CIK
- 0001779763
- Latest filing
- Feb 17, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 24
- 0 vs. Q2 2024
- Portfolio value
- $711.2M
- −$242.8M (−25.5%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MEDPMedpace Holdings, Inc. | COM | 192,842 | $64.4M | 9.1% | +192,842 | New | History |
| ELANElanco Animal Health Inc | COM | 4,263,343 | $62.6M | 8.8% | +1,034,904+32.1% | Added | History |
| ILMNIllumina, Inc. | COM | 440,000 | $57.4M | 8.1% | +440,000 | New | History |
| THCTenet Healthcare Corp | COM NEW | 308,940 | $51.3M | 7.2% | +308,940 | New | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 802,151 | $50.9M | 7.2% | −36,924−4.4% | Reduced | History |
| NVSTEnvista Holdings Corp | COM | 2,189,369 | $43.3M | 6.1% | +2,189,369 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 72,001 | $35.4M | 5.0% | −48,985−40.5% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,943,790 | $35.0M | 4.9% | −1,356,395−41.1% | Reduced | History |
| OSCROscar Health, Inc. | CL A | 1,611,909 | $34.2M | 4.8% | −220,347−12.0% | Reduced | History |
| DHRDanaher Corp | Stock | 110,000 | $30.6M | 4.3% | −77,011−41.2% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 217,674 | $28.4M | 4.0% | −290,482−57.2% | Reduced | History |
| EXASExact Sciences Corp | COM | 399,871 | $27.2M | 3.8% | +399,871 | New | History |
| PODDInsulet Corp | Stock | 110,000 | $25.6M | 3.6% | −154,041−58.3% | Reduced | History |
| MMSIMerit Medical Systems Inc | COM | 253,000 | $25.0M | 3.5% | +253,000 | New | History |
| TWSTTwist Bioscience Corp | COM | 510,000 | $23.0M | 3.2% | −16,455−3.1% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 252,266 | $22.7M | 3.2% | +252,266 | New | History |
| GERNGeron Corp | COM | 3,351,000 | $15.2M | 2.1% | +3,351,000 | New | History |
| SNYSanofi | SPONSORED ADR | 261,741 | $15.1M | 2.1% | +261,741 | New | History |
| BKDBrookdale Senior Living Inc. | COM | 2,197,578 | $14.9M | 2.1% | −3,604,363−62.1% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 180,000 | $13.1M | 1.8% | −233,196−56.4% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 750,000 | $11.5M | 1.6% | +750,000 | New | History |
| MYGNMyriad Genetics Inc | COM | 401,859 | $11.0M | 1.5% | +401,859 | New | History |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 845,470 | $8.24M | 1.2% | +845,470 | New | History |
| BCAXBicara Therapeutics Inc. | COM | 200,000 | $5.09M | 0.7% | +200,000 | New | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ELANElanco Animal Health Inc | COM | – | $10.6M |
Sold out since Q2 2024 (13)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| EWEdwards Lifesciences Corp | Stock | 727,180 | $67.2M | 7.0% | History |
| DXCMDexcom Inc | COM | 582,199 | $66.0M | 6.9% | History |
| MCKMcKesson Corp | Stock | 92,125 | $53.8M | 5.6% | History |
| ABBVAbbVie Inc. | Stock | 284,657 | $48.8M | 5.1% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 555,140 | $45.7M | 4.8% | History |
| WSTWest Pharmaceutical Services Inc | COM | 132,908 | $43.8M | 4.6% | History |
| INSPInspire Medical Systems, Inc. | COM | 281,992 | $37.7M | 4.0% | History |
| NBIXNeurocrine Biosciences Inc | Stock | 200,000 | $27.5M | 2.9% | History |
| ARGXArgenx SE | SPONSORED ADR | 61,704 | $26.5M | 2.8% | History |
| SDGRSchrodinger, Inc. | COM | 1,133,102 | $21.9M | 2.3% | History |
| AGLagilon health, inc. | COM | 2,519,416 | $16.5M | 1.7% | History |
| MASS908 Devices Inc. | COM | 728,865 | $3.75M | 0.4% | History |
| ALMSAlumis Inc. | COM | 125,000 | $1.66M | 0.2% | History |